After a Delay, AquaBounty’s GMO Salmon Available to U.S. Consumers in April


A land-based salmon farm in Indiana is preparing to make its debut on the U.S. market in the coming months after delays due to the pandemic. The first genetically engineered animal for human consumption in the U.S. could be available to consumers as soon as this April.

AquaBounty Technologies, Inc. Announces Closing of $65.2 Million Upsized Public Offering of Common Stock, Including Full Exercise of Overallotment Option

December 17, 2020 AquaBounty Technologies

AquaBounty Technologies announced the closing of its previously announced underwritten public offering of 10,028,000 shares of common stock of the Company at a price to the public of $6.50 per share.

Court Orders FDA to Assess Environmental Impact of GM Salmon

A federal court judge ordered the U.S. Food and Drug Administration on Thursday to conduct an environmental assessment of genetically modified salmon that he said was required for the agency’s approval of the fish.

AquaBounty One Step Closer to Selling GMO Salmon; Fish to be Harvested Later This Year

A rural Indiana fish farm is one step closer to getting genetically engineered salmon to store shelves. The company is harvesting its first batch of Atlantic salmon helping prepare for its inaugural GMO fish production later this year.

First Genetically Modified Salmon to Hit Canadian Stores as Ottawa Gives the Nod

Genetically modified salmon raised in Prince Edward Island are poised for the leap to grocery shelves, a Canadian first that has left traditional producers concerned about setting their farmed fish apart.